Cargando…

Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses

[Image: see text] Emerging and re-emerging infectious diseases due to RNA viruses cause major negative consequences for the quality of life, public health, and overall economic development. Most of the RNA viruses causing illnesses in humans are of zoonotic origin. Zoonotic viruses can directly be t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sperk, Maike, van Domselaar, Robert, Rodriguez, Jimmy Esneider, Mikaeloff, Flora, Sá Vinhas, Beatriz, Saccon, Elisa, Sönnerborg, Anders, Singh, Kamal, Gupta, Soham, Végvári, Ákos, Neogi, Ujjwal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640957/ https://www.ncbi.nlm.nih.gov/pubmed/33095583 http://dx.doi.org/10.1021/acs.jproteome.0c00380

Ejemplares similares

Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
por: Chen, Xi, et al.
Publicado: (2021)

Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
por: Saccon, Elisa, et al.
Publicado: (2021)

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
por: Saccon, Elisa, et al.
Publicado: (2021)

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2021)

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
por: Krishnan, Shuba, et al.
Publicado: (2021)

Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2022)

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
por: Appelberg, Sofia, et al.
Publicado: (2020)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection
por: Sperk, Maike, et al.
Publicado: (2018)

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
por: Zhang, Wang, et al.
Publicado: (2017)

Coordinated pyruvate kinase activity is crucial for metabolic adaptation and cell survival during mitochondrial dysfunction
por: Zhou, Xiaoshan, et al.
Publicado: (2021)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
por: Mikaeloff, Flora, et al.
Publicado: (2022)

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2023)

Plasma soluble factor following two decades prolonged suppressive antiretroviral therapy in HIV-1-positive males: A cross-sectional study
por: Sperk, Maike, et al.
Publicado: (2018)

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis
por: Tiwari, Ritudhwaj, et al.
Publicado: (2020)

Nucleoside-Modified mRNA Vaccines Protect IFNAR(–/–) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
por: Appelberg, Sofia, et al.
Publicado: (2022)

Emerging and Re-emerging Infectious Diseases
por: Georgiev, Vassil St.
Publicado: (2009)

Emerging and Re-emerging Infectious Diseases
por: Löscher, Thomas, et al.
Publicado: (2009)

Emerging and re-emerging infectious diseases in Iran
por: Parhizgari, Najmeh, et al.
Publicado: (2017)

The challenge of emerging and re-emerging infectious diseases
por: Morens, David M., et al.
Publicado: (2004)

Emerging and re-emerging infectious diseases: Be prepared
por: Kohn, William G.
Publicado: (2010)

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
por: Zhang, Wang, et al.
Publicado: (2018)

New and Re-Emerging Infectious Diseases
por: Docampo, Roberto
Publicado: (2004)

Mathematical and statistical modeling for emerging and re-emerging infectious diseases
por: Chowell, Gerardo, et al.
Publicado: (2016)

Emerging and Re-emerging Infectious Diseases: Public Health Perspective
por: Shrivastava, Saurabh R, et al.
Publicado: (2013)

Emerging and re-emerging infectious diseases: challenges and opportunities for militaries
por: Ho, Zheng Jie Marc, et al.
Publicado: (2014)

Emerging and Re-emerging Infectious Diseases in South East Asia
por: Sarma, Nilendu
Publicado: (2017)

Reasons for the increase in emerging and re-emerging viral infectious diseases
por: Ka-Wai Hui, Eric
Publicado: (2006)

Major factors affecting the emergence and re-emergence of infectious diseases
por: Church, Deirdre L.
Publicado: (2004)

Emerging and re-emerging infectious disease training needs in Turkey
por: Sahin, Mustafa Kursat, et al.
Publicado: (2018)

Emerging and re-emerging infectious diseases: A perpetual threat
por: Kashyap, Bineeta, et al.
Publicado: (2015)

Emerging and Re-Emerging Infectious Diseases: Humankind’s Companions and Competitors
por: Spernovasilis, Nikolaos, et al.
Publicado: (2022)

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
por: Ambikan, Anoop T., et al.
Publicado: (2022)

Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashokkumar, Manickam, et al.
Publicado: (2020)

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashok kumar, Manickam, et al.
Publicado: (2020)

Insights into Ebola and Other Emerging and Re-emerging Infectious Disease Risks
por: Kelley, Timothy R
Publicado: (2014)

Health surveillance, biosafety and emergence and re-emergence of infectious diseases in Brazil
por: de Oliveira Cardoso, Telma Abdalla, et al.
Publicado: (2010)

Facing the Global Challenges of Emerging and Re-emerging Infectious Diseases in Taiwan
por: King, C.C., et al.
Publicado: (2008)

Editorial: Innovative Approaches in Diagnosis of Emerging/Re-emerging Infectious Diseases
por: Barac, Aleksandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d8b1q12d78rcip8ct92d1ggcve